Genesis Molecular Technologies Revenue

Biotechnology Research • Austin, Texas, United States • 1-10 Employees

Genesis Molecular Technologies revenue & valuation

Annual revenue	$171,110
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$547,552
Total funding	No funding

Key Contact at Genesis Molecular Technologies

Paul Premo

Acting Chief Executive Officer

Company overview

Headquarters	Austin, Texas, United States
Website	genesismoleculartechnologies.com
NAICS	541714
Founded	2021
Employees	1-10
Socials

About Genesis Molecular Technologies

Genesis Molecular Technologies, a regenerative science company, has created a novel molecule that prompts stem cell regeneration. Based on 24 years of stem cell research, this innovative molecule was developed by a team of distinguished biologists and is capable of providing remarkable regenerative results. To discuss licensing opportunities within the cosmetic field, please contact us at www.genesismoleculartechnologies.com.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

C-Suite

Employees by Department

Genesis Molecular Technologies has 1 employees across 1 departments.

Departments

Number of employees

Funding Data

Genesis Molecular Technologies has never raised funding before.

Genesis Molecular Technologies Tech Stack

Discover the technologies and tools that power Genesis Molecular Technologies's digital infrastructure, from frameworks to analytics platforms.

Adobe Fonts

Font scripts

Modernizr

JavaScript libraries

Lodash

JavaScript libraries

reCAPTCHA

Security

Squarespace Commerce

Ecommerce

Stimulus

JavaScript frameworks

HSTS

Security

Open Graph

Miscellaneous

core-js

JavaScript libraries

Cart Functionality

Ecommerce

YUI

JavaScript libraries

Squarespace

CMS

Frequently asked questions

Genesis Molecular Technologies is located in Austin, Texas, US.

Genesis Molecular Technologies generates an estimated annual revenue of $171,110. This revenue figure reflects the company's market position and business performance in its industry.

Genesis Molecular Technologies has an estimated valuation of $547,552. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Genesis Molecular Technologies was founded in 2021, making it 5 years old. The company has established itself as a significant player in its industry over this time.

Genesis Molecular Technologies has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contact at Genesis Molecular Technologies

Paul Premo

Acting Chief Executive Officer

4.8

40,000 users